Diplomat Pharmacy Inc (DPLO):企業の財務・戦略的SWOT分析

◆英語タイトル:Diplomat Pharmacy Inc (DPLO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8013727
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月21日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Diplomat Pharmacy Inc (DPLO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Diplomat Pharmacy Inc (Diplomat Pharmacy) is a specialty pharmacy services provider. The company offers personalized medication therapies and other clinical services. It also provides pharmacy benefit management and customized care management solutions, including dispensing, delivery, dosing, and reimbursement of clinically intensive and high-cost specialty drugs. The company is licensed to dispense prescriptions in all the US states and territories. Diplomat Pharmacy’s major solutions includes patient care system, clinically based drug therapy management programs, counseling on adherence and side-effect management, drug-specific compliance and persistency programs, and clinical and administrative support services. It also provides financial assistance to patients and Hub Services for maintaining collaboration among participants in the specialty pharmacy system. Apart from these, through Diplomat University, the company provides training to external professionals, including pharmacists, payors, pharmaceutical partners, and physicians, on the specialty pharmacy industry. Diplomat Pharmacy is headquartered in Flint, Michigan, the US.

Diplomat Pharmacy Inc Key Recent Developments

Nov 06,2017: Diplomat Announces Third Quarter Financial Results
Oct 30,2017: Diplomat Names Executive Vice President of Sales, Payor Strategies
Oct 02,2017: Diplomat acquires 8th Day Software, names new CIO
Aug 07,2017: Diplomat Announces Second Quarter Financial Results
Aug 07,2017: Diplomat Announces A New President

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Diplomat Pharmacy Inc – Key Facts 5
Diplomat Pharmacy Inc – Key Employees 6
Diplomat Pharmacy Inc – Key Employee Biographies 7
Diplomat Pharmacy Inc – Major Products and Services 8
Diplomat Pharmacy Inc – History 9
Diplomat Pharmacy Inc – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 12
Diplomat Pharmacy Inc – Business Description 12
Diplomat Pharmacy Inc – Strengths 13
Diplomat Pharmacy Inc – Weaknesses 14
Diplomat Pharmacy Inc – Opportunities 15
Diplomat Pharmacy Inc – Threats 16
Diplomat Pharmacy Inc – Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios – Capital Market Ratios 18
Financial Ratios – Annual Ratios 19
Performance Chart 22
Financial Performance 22
Financial Ratios – Interim Ratios 23
Financial Ratios – Ratio Charts 24
Section 4 – Company’s Lifesciences Financial Deals and Alliances 25
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Diplomat Pharmacy Inc, Recent Deals Summary 27
Section 5 – Company’s Recent Developments 28
Nov 06, 2017: Diplomat Announces Third Quarter Financial Results 28
Oct 30, 2017: Diplomat Names Executive Vice President of Sales, Payor Strategies 30
Aug 07, 2017: Diplomat Announces Second Quarter Financial Results 31
Aug 07, 2017: Diplomat Announces A New President 33
Jun 08, 2017: Jeff Park Elected to Diplomat Board of Directors 34
May 23, 2017: Diplomat Partners With Medication Adherence Company SMRxT 35
May 08, 2017: Diplomat Announces 1st Quarter Financial Results 36
Apr 13, 2017: Diplomat Promotes Executive Jennifer Cretu 37
Apr 11, 2017: Diplomat Appoints New Chief Financial Officer 38
Apr 06, 2017: Dr. Regina Benjamin Appointed to Diplomat’s Board of Directors 39
Section 6 – Appendix 40
Methodology 40
Ratio Definitions 40
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Diplomat Pharmacy Inc, Key Facts 5
Diplomat Pharmacy Inc, Key Employees 6
Diplomat Pharmacy Inc, Key Employee Biographies 7
Diplomat Pharmacy Inc, Major Products and Services 8
Diplomat Pharmacy Inc, History 9
Diplomat Pharmacy Inc, Other Locations 10
Diplomat Pharmacy Inc, Subsidiaries 10
Diplomat Pharmacy Inc, Key Competitors 17
Diplomat Pharmacy Inc, Ratios based on current share price 18
Diplomat Pharmacy Inc, Annual Ratios 19
Diplomat Pharmacy Inc, Annual Ratios (Cont...1) 20
Diplomat Pharmacy Inc, Annual Ratios (Cont...2) 21
Diplomat Pharmacy Inc, Interim Ratios 23
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Diplomat Pharmacy Inc, Recent Deals Summary 27
Currency Codes 40
Capital Market Ratios 40
Equity Ratios 41
Profitability Ratios 41
Cost Ratios 42
Liquidity Ratios 42
Leverage Ratios 43
Efficiency Ratios 43

★海外企業調査レポート[Diplomat Pharmacy Inc (DPLO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anaconda Mining Inc:企業の戦略・SWOT・財務分析
    Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sony Mobile Communications AB.:企業の戦略的SWOT分析
    Sony Mobile Communications AB. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Mayo Clinic-医療機器分野:企業M&A・提携分析
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Interconexion Electrica S.A. E.S.P.:発電所・企業SWOT分析
    Interconexion Electrica S.A. E.S.P. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Armune BioScience Inc-医療機器分野:企業M&A・提携分析
    Summary Armune BioScience Inc (Armune) is a medical device company that develops and commercializes molecular diagnostic and prognostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or proteins. It develops protein signature based diagnostic tests fo …
  • Vietnam Electricity Construction Joint – Stock Corp (VNE):電力:M&Aディール及び事業提携情報
    Summary Vietnam Electricity Construction Joint - Stock Corp (VNECO) is a diversified company. The company operates through its business divisions such as electricity construction, industrial production, delivery of equipment, investment power, and consulting services. Its electricity construction di …
  • Kier Group plc:企業の戦略・SWOT・財務情報
    Kier Group plc - Strategy, SWOT and Corporate Finance Report Summary Kier Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Woodside Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Woodside Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Woodside Petroleum Ltd (Woodside) is an independent oil and gas company that explores, develops, produces and supplies energy. It explores and produces oil and gas from a portfolio of faciliti …
  • Hindustan Petroleum Corp Ltd (HINDPETRO):企業の財務・戦略的SWOT分析
    Hindustan Petroleum Corp Ltd (HINDPETRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Century Plyboards (India) Ltd:企業の戦略・SWOT・財務情報
    Century Plyboards (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Century Plyboards (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Phatra Leasing Public Company Limited (PL):企業の財務・戦略的SWOT分析
    Phatra Leasing Public Company Limited (PL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Dubai Electricity and Water Authority:発電所・企業SWOT分析
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Maruho Co Ltd:企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Mylan NV (MYL):医療機器:M&Aディール及び事業提携情報
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines, and consumer healthcare products. It offers pharmaceutical products in multiple forms for various disease conditions related to respiratory and allerg …
  • G1 Therapeutics Inc (GTHX)-製薬・医療分野:企業M&A・提携分析
    Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc is a healthcare company that develops novel, and small molecule therapies. The company pipeline products include CDK4/6, trilaciclib G1T28 a drug candidate; G1T38 a potential best compound, and G1T48. It undertakes disco …
  • Union des Groupements d’Achats Publics:企業の戦略的SWOT分析
    Union des Groupements d'Achats Publics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Mirage Retail Group BV:企業の戦略的SWOT分析
    Mirage Retail Group BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Lidds AB (LIDDS):企業の財務・戦略的SWOT分析
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • Avalara Inc:企業のM&A・事業提携・投資動向
    Avalara Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Avalara Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆